Related Experiment Video

Updated: Jun 2, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity

E Nicolle1, F Souard, P Faure

  • 1Université de Grenoble I/CNRS, UMR 5063, Département de Pharmacochimie Moléculaire, BP 53 F-38041 Grenoble Cedex 9, France.

Current Medicinal Chemistry
|May 17, 2011
PubMed

Insights

Antioxidant flavonoids show promise for treating type 2 diabetes by combating oxidative stress and improving glucose metabolism. Their structure-activity relationships are key to understanding their antidiabetic potential.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Metabolic Diseases

Background:

  • Hyperglycemia induces reactive oxygen species and oxidative stress, impacting the vascular system.
  • Oxidative stress, inflammation, and insulin activity are interconnected, influencing diabetes development.
  • Antioxidants offer potential in managing hyperglycemia and improving glucose metabolism.

Purpose of the Study:

  • To review antioxidant flavonoids investigated for their antidiabetic properties.
  • To explore the link between antioxidant activity and biological targets in type 2 diabetes.
  • To analyze structure-activity relationships of flavonoids in diabetes treatment.

Main Methods:

  • Literature review of studies on antioxidant flavonoids and diabetes.
  • Analysis of flavonoids targeting key enzymes and transporters in glucose metabolism.
  • Examination of structure-activity relationships for antidiabetic effects.

Main Results:

  • Flavonoids possess antioxidant properties beneficial against hyperglycemia-induced oxidative stress.
  • Many flavonoids interact with targets like alpha-glycosidase, glucose transporters, and aldose reductase.
  • Structure-activity relationship studies reveal specific flavonoid features crucial for antidiabetic action.

Conclusions:

  • Antioxidant flavonoids are promising candidates for type 2 diabetes treatment.
  • Their multifaceted actions on oxidative stress and specific molecular targets warrant further investigation.
  • Understanding structure-activity relationships can guide the development of novel flavonoid-based antidiabetic drugs.

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...